- Home
- CRNX vs AGO Comparison
CRNX vs AGO Comparison
Compare CRNX & AGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNX | AGO |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2018 | 2003 |
Fundamental Metrics
Financial Performance| Metric | CRNX | AGO |
|---|---|---|
| Price | $38.57 | $85.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $74.78 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 935.7K | 229.7K |
| Earning Date | 06-01-2026 | 06-05-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | ★ 49.34 |
| EPS | N/A | ★ 10.26 |
| Revenue | $1,039,000.00 | ★ $1,110,000,000.00 |
| Revenue This Year | $730.30 | N/A |
| Revenue Next Year | $179.48 | $4.51 |
| P/E Ratio | ★ N/A | $8.47 |
| Revenue Growth | N/A | ★ 27.29 |
| 52 Week Low | $24.10 | $74.09 |
| 52 Week High | $57.99 | $92.40 |
Technical Indicators
Market Signals| Indicator | CRNX | AGO |
|---|---|---|
| Relative Strength Index (RSI) | 26.18 | 45.58 |
| Support Level | $33.23 | $83.17 |
| Resistance Level | $45.32 | $87.39 |
| Average True Range (ATR) | 1.87 | 2.03 |
| MACD | -0.40 | -0.00 |
| Stochastic Oscillator | 6.93 | 30.87 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.